Log In
Print this Print this

BI 853520

  Manage Alerts
Collapse Summary General Information
Company Boehringer Ingelheim GmbH
DescriptionProtein tyrosine kinase 2 (PTK2) inhibitor
Molecular Target Protein tyrosine kinase 2 (PTK2)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today